AAAAAA
Results:
1-7
|
Results: 7
Authors:
Isla, D
Rosell, R
Sanchez, JJ
Carrato, A
Felip, E
Camps, C
Artal, A
Gonzalez-Larriba, JL
Azagra, P
Alberola, J
Martin, C
Massuti, B
Citation: D. Isla et al., Phase II trial of paclitaxel plus gemcitabine in patients with locally advanced or metastatic non-small-cell lung cancer, J CL ONCOL, 19(4), 2001, pp. 1071-1077
Authors:
Colomer, R
Montero, S
Lluch, A
Ojeda, B
Barnadas, A
Casado, A
Massuti, B
Cortes-Funes, H
Lloveras, B
Citation: R. Colomer et al., Circulating HER2 extracellular domain and resistance to chemotherapy in advanced breast cancer, CLIN CANC R, 6(6), 2000, pp. 2356-2362
Authors:
Sacristan, JA
Kennedy-Martin, T
Rosell, R
Cardenal, F
Anton, A
Lomas, M
Alberola, V
Massuti, B
Carrato, A
Minshall, M
Citation: Ja. Sacristan et al., Economic evaluation in a randomized phase III clinical trial comparing gemcitabine/cisplatin and etoposide/cisplatin in non-small cell lung cancer, LUNG CANC, 28(2), 2000, pp. 97-107
Authors:
Lluch, A
Ojeda, B
Colomer, R
Barnadas, A
Massuti, B
Casado, A
Angeles, C
Maroto, P
Citation: A. Lluch et al., Doxorubicin and paclitaxel in advanced breast carcinoma - Importance of prior adjuvant anthracycline therapy, CANCER, 89(11), 2000, pp. 2169-2175
Authors:
Martin, C
Romero, S
Sanchez-Paya, J
Massuti, B
Arriero, JM
Hernandez, L
Citation: C. Martin et al., Bilateral lymphocytic alveolitis: a common reaction after unilateral thoracic irradiation, EUR RESP J, 13(4), 1999, pp. 727-732
Authors:
Cardenal, F
Lopez-Cabrerizo, MP
Anton, A
Alberola, V
Massuti, B
Carrato, A
Barneto, I
Lomas, M
Garcia, M
Lianes, P
Montalar, J
Vadell, C
Gonzalez-Larriba, JL
Nguyen, B
Artal, A
Rosell, R
Citation: F. Cardenal et al., Randomized phase III study of gemcitabine-cisplatin versus etoposide-cisplatin in the treatment of locally advanced or metastatic non-small-cell lungcancer, J CL ONCOL, 17(1), 1999, pp. 12-18
Authors:
Villar-Grimalt, A
Candel, MT
Massuti, B
Lizon, J
Sanchez, B
Frau, A
Gorostidi, B
Goedkoop, R
Citation: A. Villar-grimalt et al., A randomized phase II trial of 5-fluorouracil, with or without human interferon-beta, for advanced colorectal cancer, BR J CANC, 80(5-6), 1999, pp. 786-791
Risultati:
1-7
|